Novel benzoimidazole derivatives useful as antiproliferative agents

Details for Australian Patent Application No. 2003250499 (hide)

Owner Pfizer Products Inc.

Inventors Lyssikatos, Joseph Peter; Kath, John Charles; Wang, Huifen Faye

Agent Shelston IP

Pub. Number AU-B-2003250499

PCT Number PCT/IB03/03634

PCT Pub. Number WO2004/020431

Priority 60/406,524 28.08.02 US; 60/417,047 08.10.02 US

Filing date 14 August 2003

Wipo publication date 19 March 2004

Acceptance publication date 23 April 2009

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/00 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 60/406,524 28.08.02 US; 60/417,047 08.10.02 US

6 May 2004 Application Open to Public Inspection

  Published as AU-B-2003250499

23 April 2009 Application Accepted

  Published as AU-B-2003250499

20 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003250500-METAL ELECTROWINNING CELL WITH ELECTROLYTE PURIFIER

2003250498-PROCESSING APPLICATION DATA